Related references
Note: Only part of the references are listed.Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer
Fabrice Andre et al.
CLINICAL CANCER RESEARCH (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An evolutionary perspective on anti-tumor immunity
David J. Klinke
FRONTIERS IN ONCOLOGY (2013)
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
Hollie J. Pegram et al.
BLOOD (2012)
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Douglas G. Altman et al.
BMC MEDICINE (2012)
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
Stefan Glueck et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model
Yogesh M. Kulkarni et al.
INTEGRATIVE BIOLOGY (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis
Michail Ignatiadis et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancer immunoediting by the innate immune system in the absence of adaptive immunity
Timothy O'Sullivan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Expression of tumour-specific antigens underlies cancer immunoediting
Michel DuPage et al.
NATURE (2012)
Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system
Metamia Ciampricotti et al.
NATURE MEDICINE (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Protein-based identification of quantitative trait loci associated with malignant transformation in two HER2+cellular models of breast cancer
Yogesh M. Kulkarni et al.
PROTEOME SCIENCE (2012)
Quantifying Crosstalk Among Interferon-γ, Interleukin-12, and Tumor Necrosis Factor Signaling Pathways Within a TH1 Cell Model
David J. Klinke et al.
SCIENCE SIGNALING (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
WISP-1/CCN4 Regulates Osteogenesis by Enhancing BMP-2 Activity
Mitsuaki Ono et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Development of metastatic HER2+ breast cancer is independent of the adaptive immune system
Metamia Ciampricotti et al.
JOURNAL OF PATHOLOGY (2011)
Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer
Takayuki Iwamoto et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
David Venet et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma
T. Maruyama et al.
BRITISH JOURNAL OF CANCER (2010)
Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
Andrew L. Doedens et al.
CANCER RESEARCH (2010)
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Sid P. Kerkar et al.
CANCER RESEARCH (2010)
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
Kiavash Movahedi et al.
CANCER RESEARCH (2010)
GATA3 in Development and Cancer Differentiation: Cells GATA Have It!
Jonathan Chou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Tumor Antigen-Targeted, Monoclonal Antibody-Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
Robert L. Ferris et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Towards a knowledge-based Human Protein Atlas
Mathias Uhlen et al.
NATURE BIOTECHNOLOGY (2010)
Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells
John J. O'Shea et al.
SCIENCE (2010)
Scalable Analysis of Flow Cytometry Data Using R/Bioconductor
David J. Klinke et al.
CYTOMETRY PART A (2009)
Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in Lineage Fate Determination of Differentiating CD4+ T Cells
Gang Wei et al.
IMMUNITY (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems
Tina Toni et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation
I-Cheng Ho et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
Tamer T. Onder et al.
CANCER RESEARCH (2008)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
TGF-β1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function
Colette A. Inkson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer
Simon R. Davies et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E. Teschendorff et al.
GENOME BIOLOGY (2007)
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Jason I. Herschkowitz et al.
GENOME BIOLOGY (2007)
Adoptive transfer of tumor-primed, in vitro-activated, CD4(+) T effector cells (T(E)s) combined with CD8(+) T(E)s provides intraturnoral T-E proliferation and synergistic antitumor response
Li-Xin Wang et al.
BLOOD (2007)
Cancer as an evolutionary and ecological process
Lauren M. F. Merlo et al.
NATURE REVIEWS CANCER (2006)
The ratio of P40 monomer to dimer is an important determinant of IL-12 bioactivity
DJ Klinke
JOURNAL OF THEORETICAL BIOLOGY (2006)
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: Correlation with important high-risk prognostic factors
Hazem Ghebeh et al.
NEOPLASIA (2006)
A human protein atlas for normal and cancer tissues based on antibody proteomics
M Uhlén et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Lack of Il12rb2 signaling predisposes to,spontaneous autoimmunity and malignancy
I Airoldi et al.
BLOOD (2005)
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies:: Analysis of sustained interferon γ production in a subset of patients
R Parihar et al.
CLINICAL CANCER RESEARCH (2004)
HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway
F Herrmann et al.
CANCER RESEARCH (2004)
Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands:: Involvement of physical association between PPAR-γ and the nuclear factor of activated T cells transcription factor
SW Chung et al.
MOLECULAR PHARMACOLOGY (2003)
Peroxisome proliferator-activated receptors α and γ down-regulate allergic inflammation and eosinophil activation
G Woerly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor β1 deficiency:: Medical and immunological implications
C Fieschi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Inherited interleukin-12 deficiency:: IL12B genotype and clinical phenotype of 13 patients from six kindreds
C Picard et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Reverse engineering of biological complexity
ME Csete et al.
SCIENCE (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
